Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Thank you for standing by ...

Should you invest in Bicara Therapeutics Inc? Click for more on BCAX's promising cancer treatment, but proceed with caution ...

NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView, a leading provider of market insights and company news, proudly ...

Mineralys Therapeutics, Inc. ( (MLYS) ) has released its Q3 earnings. Here is a breakdown of the information Mineralys Therapeutics, Inc.

CHAPEL HILL, N.C. (AP) — CHAPEL HILL, N.C. (AP) — Tenax Therapeutics Inc. (TENX) on Wednesday reported a loss of $4 million in its third quarter. On a per-share basis, the Chapel Hill, North ...

Investors consider Dyne Therapeutics' treatments for muscle diseases and strong cash position as a speculative Buy ...

Last patient completed pivotal Phase 3 trial in CHB-associated liver fibrosis in the PRC with data expected in Q1 2025 On track to initiate U.S. Phase 2 trial of F351 in MASH-associated liver fibrosis ...

Wells Fargo has recently raised Travere Therapeutics Inc (TVTX) stock to Overweight rating, as announced on October 21, 2024, according to Finviz. Earlier, on October 16, 2024, Scotiabank had ...

Data presented as part of a poster at the SITC 2024 Conference SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- ...

On Friday, Amicus Therapeutics, Inc. (FOLD) stock saw a modest uptick, ending the day at $10.99 which represents a slight increase of $0.01 or 0.09% from the prior close of $10.98. The stock opened at ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning, and welcome to the Axsome Therapeutics Third ...